Viewing Study NCT05769595


Ignite Creation Date: 2025-12-24 @ 2:13 PM
Ignite Modification Date: 2026-01-29 @ 5:30 PM
Study NCT ID: NCT05769595
Status: COMPLETED
Last Update Posted: 2025-03-14
First Post: 2023-03-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Single Dose Study of MK-2060 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Older Japanese Participants on Dialysis (MK-2060-012)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None End-Stage Renal Disease (ESRD) View
None End-Stage Kidney Disease (ESKD) View
None Kidney Failure, Chronic View
Keywords: